{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:41:57Z","timestamp":1784306517940,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.msard.2022.104160","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T03:11:43Z","timestamp":1662520303000},"page":"104160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study"],"prefix":"10.1016","volume":"68","author":[{"given":"Nabil K. El","family":"Ayoubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ribal","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-6063","authenticated-orcid":false,"given":"Samia J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.104160_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jns.2017.11.017","article-title":"High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status","volume":"384","author":"Bertsch-Gout","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2022.104160_bib0002","article-title":"Applying an opensource segmentation algorithm to different OCT devices in multiple sclerosis patients and healthy controls: implications for clinical trials","volume":"2015","author":"Bhargava","year":"2015","journal-title":"Mult. Scler. Int."},{"issue":"3","key":"10.1016\/j.msard.2022.104160_bib0003","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/WNO.0b013e31829f39f1","article-title":"The retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosis","volume":"33","author":"Bichuetti","year":"2013","journal-title":"J. Neuroophthalmol."},{"issue":"24","key":"10.1016\/j.msard.2022.104160_bib0004","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"86","author":"Cruz-Herranz","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2022.104160_bib0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1148\/rg.2018184002","article-title":"Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis\u2014erratum","volume":"38","author":"Dutra","year":"2018","journal-title":"RadioGraphics"},{"issue":"7","key":"10.1016\/j.msard.2022.104160_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1756285617709723","article-title":"Differential diagnosis of neuromyelitis optica spectrum disorders","volume":"10","author":"Kim","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"4","key":"10.1016\/j.msard.2022.104160_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7224\/1537-2073-14.4.209","article-title":"Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging","volume":"14","author":"Lalan","year":"2012","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2022.104160_bib0008","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1364\/BOE.4.001133","article-title":"Retinal layer segmentation of macular OCT images using boundary classification","volume":"4","author":"Lang","year":"2013","journal-title":"Biomed. Opt. Express"},{"key":"10.1016\/j.msard.2022.104160_bib0009","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nicl.2016.05.014","article-title":"Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica","volume":"11","author":"Manogaran","year":"2016","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.msard.2022.104160_bib0010","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.104160_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00493","article-title":"The contribution of optical coherence tomography in neuromyelitis optica spectrum disorders","volume":"8","author":"Mateo","year":"2017","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.104160_bib0012","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the united states: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2022.104160_bib0013","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","article-title":"Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis","volume":"72","author":"Naismith","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104160_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/472790","article-title":"Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update","volume":"2011","author":"Noval","year":"2011","journal-title":"Mult. Scler. Int."},{"issue":"12","key":"10.1016\/j.msard.2022.104160_bib0015","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/jnnp-2018-318382","article-title":"Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study","volume":"89","author":"Oertel","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.104160_bib0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-319-20970-8_6","article-title":"OCT findings in neuromyelitis optica spectrum disorders","author":"Outteryck","year":"2016","journal-title":"Opt. Coherence Tomogr. Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2022.104160_bib0017","first-page":"92","article-title":"Analysis of spectral domain optical coherence tomography measurements in optic neuritis: Differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls","author":"Park","year":"2014","journal-title":"Acta Ophthalmol."},{"issue":"10","key":"10.1016\/j.msard.2022.104160_bib0019","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/1352458519861603","article-title":"Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography","volume":"26","author":"Pisa","year":"2019","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2022.104160_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","article-title":"Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies","volume":"73","author":"Ratchford","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104160_bib0021","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.24487","article-title":"Optical coherence tomography reflects brain atrophy in MS: a four year study","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.104160_bib0022","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/1352458511418630","article-title":"Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness","volume":"17","author":"Saidha","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.104160_bib0023","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/brain\/awq346","article-title":"Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography","volume":"134","author":"Saidha","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2022.104160_bib0024","doi-asserted-by":"crossref","first-page":"e66151","DOI":"10.1371\/journal.pone.0066151","article-title":"Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis","volume":"8","author":"Schneider","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.msard.2022.104160_bib0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ophtha.2018.06.022","article-title":"Differing structural and functional patterns of optic nerve damage in multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"126","author":"Shen","year":"2019","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.msard.2022.104160_bib0026","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/1352458519864928","article-title":"Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning","volume":"26","author":"Sotirchos","year":"2020","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2022.104160_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2022.104160_bib0028","first-page":"1","article-title":"Evaluation of retinal nerve fiber layer and ganglion cell complex in patients with optic neuritis or neuromyelitis optica spectrum disorders using optical coherence tomography in a Chinese cohort","volume":"2015","author":"Tian","year":"2015","journal-title":"J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.msard.2022.104160_bib0029","first-page":"9","article-title":"In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis","author":"Vabanesi","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.msard.2022.104160_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International Panel for NMO diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822006678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822006678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:04:51Z","timestamp":1761901491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822006678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"alternative-id":["S2211034822006678"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104160","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104160"}}